Latest highlights

  • Who’s paying your doctor? 15 April 2014

    While government strongly encourages us to strengthen collaboration with industry, in order 'to improve UK health and wealth', there is also fear of contact (Berührungsangst - we Germans have a word for it), bordering on moral panic, which seems to justify Panorama's under cover work (see below). I know that doctors are sufficiently perceptive to understand that drug companies are accountable to their share holders, while doctors owe the same to their patients and their conscience. The question is, how do companies know which treatments are needed and acceptable, and how do doctors learn about new drug developments, if there is no contact between the two? Furthermore, would we trust NHS functionaries to make such decisions for us? In the end, trust grows between individual doctors and their patients (or not as the case may be). Klaus Ebmeier (Editor)

  • Course on Network Meta-Analysis (14th – 16th July 2014) 7 April 2014

    How to appraise, interpret and publish a network meta-analysis A 3-day course for clinicians, researchers and policy makers, with formal lectures and group work

  • Werther Fever 7 April 2014

    Eminent figures such as Professor Keith Hawton of Oxford University have been warning the media for years about copycat suicide. We need to remember that one in six of those who read newspapers and watch TV has a mental health problem and that 6,000 people take their lives every year – that's 16 families bereaved every day.

  • First UK study of ketamine for people with severe depression 4 April 2014

    Our Rupert McShane presents the first UK study of the use of ketamine intravenous infusions in people with treatment-resistant depression. 'Ketamine is a promising new antidepressant which works in a different way to existing antidepressants. We wanted to see whether it would be safe if given repeatedly, and whether it would be practical in an NHS setting. We especially wanted to check that repeated infusions didn't cause cognitive problems,' explains principal investigator Dr Rupert McShane, a consultant psychiatrist at Oxford Health and a researcher in Oxford University's Department of Psychiatry.

  • Additional DPhil Studentship to Start in October 2014 2 April 2014

    DPhil Studentship available to start in October 2014: Investigating selective attention to emotion in older adults.

  • Dr Belinda Lennox appointed Clinical Director of the Thames Valley and South Midlands NIHR Clinical Research Network 1 April 2014

    Belinda Lennox said: "This is an exciting time to be getting involved in the new, local Clinical Research Network. We are starting from an enviable position in our region of strong existing collaborations and research activity seen across every specialty area. We look forward to building on this with the goal that every person using NHS services in our region will have the opportunity to take part in high quality research"

  • Gender, Dreams and Visions 17 March 2014

    The University Engagement Programme at the Ashmolean Museum, funded by the Andrew W Mellon Foundation, was established in 2012 to explore ways of using the museum's collections in the teaching of the university, beyond its core disciplines of Art History, Classics and Archaeology. Over the course of its first year the Programme has begun to work with the Medical School and the NHS in undergraduate, postgraduate and professional training in cardiology, neurology and psychiatry. Over the past year, groups of psychiatric consultants, registrars and core trainees have visited the Ashmolean to consider questions raised by the depiction of emotions and ageing in paintings, drawings, prints and sculpture. Sessions are held in the galleries and in the Museum study room, and are led by art historian and curator Dr Jim Harris. Participants of previous sessions have been very enthusiastic about the programme and have found this a valuable way to reflect on their clinical practice.